Commensal control of C. difficile virulence
Commensal control of C. difficile virulence
批准号:
10211712
负责人:
LYNN BRY
金额:
$74.84万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-02-01 至 2026-01-31
关键词:
Amino AcidsAntibioticsBile AcidsBiological MarkersBiomassButyratesCarbohydratesCarbonClindamycinClostridiumClostridium bifermentansClostridium difficileCoenzyme AColonComplexDiseaseEnvironmentEtiologyFermentationGenesGeneticGerminationGlycineGrowthHealth Care CostsHumanHydro-LyasesHydrolaseIn VitroIndividualInfectionInfection preventionIntervention StudiesKnowledgeLeucineMediatingMetabolicMetabolic PathwayMetabolismMicrobeMorbidity - disease rateMusNutrientOralOutcomeOxidantsOxidoreductasePathway interactionsPatientsPopulationProductionProlinePseudomembranous ColitisReproduction sporesResourcesSourceSystemTestingTissuesToxic MegacolonToxinVirulenceVirulentWeight Gainbile saltsbiological adaptation to stressfecal transplantationhuman microbiotain vivometabolomicsmicrobiotamortalitymutantpathogenpreventprogramstranscriptomics
中文摘要
摘要: 艰难梭菌是伪膜性结肠炎的病因,可引起实质性的并发症。
发病率、死亡率以及美国每年近 50 亿美元的医疗费用。共生体提供
通过潜在的作用机制对艰难梭菌感染提供主要保护
仍然不明确。我们已经确定了能够长期生存的单个细菌种类
对抗强毒力的艰难梭菌菌株和其他可能使感染恶化的物种。我们的
拟议的目标将定义具体的共生活动和介导这些活动的共生基因
对病原体的影响,并在携带小鼠与人类复合物的小鼠体内测试其功能
微生物群,用于开发明确的细菌治疗剂和生物标志物来预测
成功的治疗。
英文摘要
Abstract: Clostridioides difficile, the etiology of pseudomembranous colitis, causes substantive
morbidity, mortality and close to $5 billion/year in US healthcare costs. Commensals provide
primary protection against C. difficile infections though the underlying mechanisms of action
remain ill-defined. We have identified individual bacterial species that provide long-term survival
against virulent C. difficile strains, and other species that can make the infection worse. Our
proposed aims will define specific commensal activities and commensal genes mediating these
effects on the pathogen, and test their functions in vivo, in mice carrying mouse vs human complex
microbiota, for the purposes of developing defined bacteriotherapeutics and biomarkers to predict
successful therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NMR-resolved dynamics of C. difficile metabolism
-
批准号:10574895
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2022
-
负责人:LYNN BRY
-
依托单位:
Commensal control of C. difficile virulence
-
批准号:10334540
-
项目类别:
-
资助金额:$67.37万
-
财政年份:2021
-
负责人:LYNN BRY
-
依托单位:
Commensal control of C. difficile virulence
-
批准号:10556405
-
项目类别:
-
资助金额:$67.37万
-
财政年份:2021
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:8511759
-
项目类别:
-
资助金额:$37.33万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Crimson - i2b2 integration for high-throughput, scalable sample collection
-
批准号:7698313
-
项目类别:
-
资助金额:$44.46万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:8304230
-
项目类别:
-
资助金额:$41.1万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:8114180
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:8239799
-
项目类别:
-
资助金额:$3.31万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:7932782
-
项目类别:
-
资助金额:$34.93万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Crimson - i2b2 integration for high-throughput, scalable sample collection
-
批准号:7918185
-
项目类别:
-
资助金额:$44.5万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Epithelial Glycoconjugates as Barriers against Enteric Infections
-
批准号:7738696
-
项目类别:
-
资助金额:$34.94万
-
财政年份:2009
-
负责人:LYNN BRY
-
依托单位:
Protective role of cross-reactive anti-enteric antibody
-
批准号:6875700
-
项目类别:
-
资助金额:$16.21万
-
财政年份:2004
-
负责人:LYNN BRY
-
依托单位:
Protective role of cross-reactive anti-enteric antibody
-
批准号:6766062
-
项目类别:
-
资助金额:$16.21万
-
财政年份:2004
-
负责人:LYNN BRY
-
依托单位:
Role of T cells in self-limited mucosal infections
-
批准号:7096555
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2003
-
负责人:LYNN BRY
-
依托单位:
Role of T cells in self-limited mucosal infections
-
批准号:6781714
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2003
-
负责人:LYNN BRY
-
依托单位:
Role of T cells in self-limited mucosal infections
-
批准号:6922803
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2003
-
负责人:LYNN BRY
-
依托单位:
Role of T cells in self-limited mucosal infections
-
批准号:6680658
-
项目类别:
-
资助金额:$11.77万
-
财政年份:2003
-
负责人:LYNN BRY
-
依托单位:
Gnotobiotics, Microbiology and Metagenomics Core
-
批准号:10049386
-
项目类别:
-
资助金额:$31.6万
-
财政年份:1997
-
负责人:LYNN BRY
-
依托单位:
GNOTOBIOTICS AND MICROBIOLOGY CORE
-
批准号:8565001
-
项目类别:
-
资助金额:$17.9万
-
财政年份:1997
-
负责人:LYNN BRY
-
依托单位:
Gnotobiotics, Microbiology and Metagenomics Core
-
批准号:10378466
-
项目类别:
-
资助金额:$27.75万
-
财政年份:1997
-
负责人:LYNN BRY
-
依托单位:
海外基金